Mandiri Herindo Adiperkasa Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp141 (market cap 2.33T, 2.7M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 4.9× Mandiri Herindo Adiperkasa Tbk.'s market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (2.7M versus 1.77M). Which is the better fit depends on your goals.
| MAHA | TSPC | |
|---|---|---|
Market Cap | 2.33T | 11.36T |
Volume | 2.7M | 1.77M |
Lot | 27K | 17.71K |
Turnover | 378.94M | 4.61B |
Average Price | 140.36 | 2,603.9 |
Value | 378.94M | 4.61B |
Indicative Equilibrium Price | 142 | 2,590 |
Indicative Equilibrium Volume | 20 | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →